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Abstract
Background: Negative energy balance (NEB) is an imbalance between energy intake and energy requirements for
lactation and body maintenance affecting high-yielding dairy cows and is of considerable economic importance
due to its negative impact on fertility and health in dairy herds. It is anticipated that the cow hypothalamus experiences
extensive biochemical changes during the early post partum period in an effort to re-establish metabolic homeostasis.
However, there is variation in the tolerance to NEB between individual cows. In order to understand the genomic
regulation of ovulation in hypothalamic tissue during NEB, mRNA transcriptional patterns between tolerant and
sensitive animals were examined. A short term dietary restriction heifer model was developed which induced
abrupt onset of anoestrus in some animals (Restricted Anovulatory; RA) while others maintained oestrous cyclicity
(Restricted Ovulatory; RO). A third control group (C) received a higher level of normal feeding.
Results: A total of 15,295 genes were expressed in hypothalamic tissue. Between RA and C groups 137 genes
were differentially expressed, whereas between RO and C, 32 genes were differentially expressed. Differentially
expressed genes were involved in the immune response and cellular motility in RA and RO groups, respectively,
compared to C group. The largest difference between groups was observed in the comparison between RA and
RO heifers, with 1094 genes shown to be significantly differentially expressed (SDE). Pathway analysis showed
that these SDE genes were associated with 6 canonical pathways (P < 0.01), of which neuroactive ligand-receptor
interaction was the most significant. Within the comparisons the main over-represented pathway functions were
immune response including neuroprotection (CXCL10, Q1KLR3, IFIH1, IL1 and IL8; RA v C and RA v RO); energy
homeostasis (AgRP and NPY; RA v RO); cell motility (CADH1, DSP and TSP4; RO v C) and prevention of GnRH release
(NTSR1 IL1α, IL1β, NPY and PACA; RA v RO).
Conclusions: This information will assist in understanding the genomic factors regulating the influence of diet
restriction on fertility and may assist in optimising nutritional and management systems for the improvement in
reproductive performance.
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Background
Over the decades great emphasis has been placed on se-
lective breeding for milk yield in dairy cows resulting in
cows being unable to meet the energy demands of main-
tenance and lactation with consequential mobilisation of
body reserves to meet these demands. Such cows are de-
scribed as being in NEB. Excessive and/or prolonged
NEB negatively impacts on reproductive performance
and increases the cows’ susceptibility to disease [1]. Dur-
ing periods of severe NEB, animals are forced to channel
available energy toward survival and away from pro-
cesses such as reproduction [2]. Normal ovarian func-
tion is therefore delayed in such animals until the energy
deficit is at least partially corrected. There is also evi-
dence that a proportion of animals will resume cyclicity
sooner than others despite all animals being at a similar
energy balance [3, 4]. Mackey et al. [5] reported that
some animals will continue to ovulate, while others will
become anovulatory when placed on a severely restricted
diet despite no differences in weight or body condition
score (BCS) at the beginning of a feeding phase.
Hormones such as insulin [6], IGF-1 [7], GH [8] leptin
[9], and nutrients such as glucose [6] and fatty acids [9]
have been implicated in signalling nutritional status.
These signals act within the hypothalamus to regulate
feed intake, energy expenditure and neuroendocrine
functions including reproduction [10–12]. The hypothal-
amus is central to the neural control of homeostasis.
Neurons in the hypothalamus are responsive to changes
in metabolic status [12, 13] and appear to play an im-
portant role in mediating the effects of nutrition on
reproduction via the hypothalamic-pituitary ovarian axis
[14]. Gonadotrophin releasing hormone (GnRH) is the
primary reproductive hormone secreted from the hypo-
thalamus that integrates a multitude of internal and en-
vironmental cues to regulate the secretion of luteinizing
hormone (LH) and follicle stimulating hormone (FSH)
from the anterior pituitary gland [15].
The effects of nutrition on reproduction are most
likely mediated through the hypothalamic-pituitary-
ovarian axis [16]. We have developed a short term diet-
ary restriction heifer model facilitating animals to be
characterised as sensitive or tolerant to an energy deficit
based on their ability to ovulate while fed a restricted
diet [17]. Approximately a third of heifers became
anoestrous due to diet restriction. As expected, follicular
growth rate and maximum diameter were reduced by
diet restriction, with larger dominant follicles more likely
to ovulate. Walsh et al. [18] showed that dietary restric-
tion altered gene expression in the dominant follicle of
the ovary potentially leading to reduced oestradiol
synthesis, FSH-responsiveness and IGF signalling in
granulosa, and LH-responsiveness in theca cells of
dominant follicles. Furthermore, steroid biosynthesis
within developing follicles was also altered suggesting
that cholesterol transport into mitochondria to initiate
steroidogenesis was affected [19].
Genes expressed in the hypothalamus are suggested to
be involved in processing estrous behaviour in cattle [20,
21]. While candidate gene expression studies have been
performed [13, 17], there are no published studies on
the application of RNAseq to analyse hypothalamic tis-
sue of individual animals in response to diet restriction.
Thus the objective of this study was to compare differ-
ences in transcriptional profiles in hypothalamic tissue
between these two groups of animals in an energy deficit
but with divergent reproductive performance, and to a
third control group on a higher level of feeding using
RNAseq and pathway analysis.
Results
Transcriptional profile of the bovine hypothalamus
On average close to 25.5 million fragments were se-
quenced for each sample. Of these 16 million, or ap-
proximately 60%, were mapped to the bovine genome by
bowtie (Table 1). On average, 9 million mapped reads
remained after filtering out reads with more than 1
alignment to the genome and reads that mapped to
exactly the same position on the genome (i.e. putative
PCR duplicates). Approximately 4 million reads per sam-
ple were mapped to annotated exons by HTseq. An
overview of these data is given in Table 1. Following ex-
clusion of genes with fewer than 5 reads for one sample
in any of the 3 groups, 15,295 genes were detected as
expressed. The RNAseq data have been deposited in
NCBI’s Gene Expression Omnibus [22] and are access-
ible through GEO Series accession number GSE49540.
Identification of significantly differentially expressed
(SDE) genes
Three comparisons of differential gene expression were
carried out. These were RA v C, RA v RO, and RO v C.
SDE genes were called at a false discover rate (FDR) of
0.1 using the DEseq package in R, which models data as
a negative binomial distribution. After statistical analysis
Table 1 Summary of sequencing read alignment to the bovine
genome
Process
Total sequenced fragments 25,512,814
Fragments mapped to nuclear genome 16,035,986
Percentage mapped 62.9%
Uniquely mapped fragments 12,655,723
Percentage uniquely mapped 78.9%
Fragments without duplicates 9,436,348
Fragments mapped to annotated genes 3,888,758
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with DEseq a total of 69 genes had increased expression
and 68 displayed decreased expression in the RA rela-
tive to C comparison (Additional file 1: Table S1). Fif-
teen genes had increased expression and 17 had
decreased expression in the RO relative to C compari-
son (Additional file 2: Table S2). The comparison with
the greatest number of SDE genes was RA v RO where
351 genes were observed to have increased expression
and 743 decreased expression in the RA relative to RO
comparison (Additional file 3: Table S3).
Pathway analysis
To gain insights into the biological processes occurring
in the hypothalamus that result in anovulation due to
diet restriction, three gene ontology and pathway ana-
lysis tools were applied. These included GOseq, Inna-
tedb and Ingenuity Pathway Analysis.
GOseq
Enrichment of SDE genes in gene ontology (GO) terms
was tested. GO annotations of genes with a FDR < 0.1
from DEseq analysis were tested against all gene annota-
tions in the GOseq database. 145 GO terms were
enriched (P < 0.01) in the comparison between RA and
C. 47 GO terms were enriched (P < 0.01) between RO
and C. And finally, 238 GO terms were enriched
(P < 0.01) when RA and RO were compared. The top 10
GO terms for each comparison are listed in Table 2.
Innatedb
SDE genes were normalised for gene length bias and
were then mapped to the Innatedb database for pathway
analysis using GOseq. From this mapping, a total of 12,
15, and 6 genetic pathways were found to be enriched
(P < 0.01) in the RA v C, RO v C, and RA v RO compar-
isons, respectively. Only 16 and 6 SDE genes resulted in
the enrichment of these pathways in the RA v C and RO
v C comparisons. However, 58 SDE genes resulted in 6
enriched pathways in the RA v RO comparison. The
small number of SDE genes resulting in a number of
pathways becoming enriched was due to genes being
present in multiple pathways. Pathways representing
each comparison are listed in Tables 3, 4 and 5.
Ingenuity pathway analysis
To determine the molecular changes occurring that re-
sult in a proportion of heifers to become anovulatory, a
2nd gene ontology tool, Ingenuity Pathway Analysis
(IPA), was used to analyse gene expression data. IPA
returned a total of 9, 1 and 11 canonical pathways for
RA v C, RO v C and RA v RO comparisons (Table 6).
Discussion
Notable variation exists in the tolerance to NEB between
individual cows with some animals displaying sensitivity
and fail to cycle while other animals remain tolerant and
Table 2 Enriched GO terms for all comparisons
Go Term Ontologya P value
Restricted Anovulatory v Control
Defense response bp 4.79E-09
Type I interferon-mediated signaling
pathway
bp 1.15E-06
Cellular response to type I interferon bp 1.15E-06
Response to type I interferon bp 1.29E-06
Response to other organism bp 1.70E-06
Immune response bp 3.71E-06
Response to biotic stimulus bp 3.96E-06
Response to virus bp 5.36E-06
Innate immune response bp 5.47E-06
Gated channel activity mf 8.57E-06
Restricted Ovulatory v Control
Establishment of synaptic specificity at
neuromuscular junction
bp 0.001550394
Collagen type XV cc 0.001734458
Cell-cell adherens junction cc 0.001885389
Cellular component disassembly at cellular
level
bp 0.002858457
Cellular component disassembly bp 0.002995423
Macrophage colony-stimulating factor
receptor binding
mf 0.003064441
Endothelial cell-cell adhesion bp 0.003122893
Thyroid-stimulating hormone receptor
activity
mf 0.003136574
Myoblast migration bp 0.003153657
Transforming growth factor beta receptor
complex assembly
bp 0.003216917
Restricted Ovulatory v Restricted Anovulatory
Neuron projection cc 6.75E-09
Cell periphery cc 2.54E-08
Plasma membrane cc 3.71E-08
G-protein coupled receptor protein
signaling pathway
bp 1.87E-07
Receptor activity mf 1.18E-06
Signal transducer activity mf 1.20E-06
Molecular transducer activity mf 1.20E-06
Dendrite cc 1.85E-06
Cell surface receptor linked signaling
pathway
bp 7.16E-06
Intrinsic to membrane cc 9.48E-06
aGene ontology terms: bp: biological process; mf: molecular function; cc:
cellular component
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continue to cycle [5]. The aim of this study was to estab-
lish the global shifts in gene expression profiles which
contribute to animals becoming anovulatory following a
period of dietary restriction. Results from the current
study are discussed below under the following three
comparisons: RA v C, RA v RO, and RO v C. Within the
comparisons, the main over-represented pathway func-
tions appear to be immune response (RA v C and RA v
RO); energy homeostasis (RA v RO); and prevention of
GnRH release (RA v RO).
Restricted Ovulatory v Control
Cellular motility
Of the 6 SDE genes resulting in pathway enrichment for
the RO v C comparison, down regulation of 3 of these
genes increases cellular motility. CADH1, DSP and TSP4
all exhibited reduced expression in RO relative to C.
CADH1 is a cadherin that encodes a cell-cell adhesion
glycoprotein, therefore reduced expression of this gene
decreases the strength of cellular adhesion thus increas-
ing cellular motility. DSP encodes desmoplakin, a
Table 3 Enriched genetic pathways between Restricted Anovulatory and Control groups from Innatedb
Pathway name Genes Total no. of genes
in pathway
P value
RIG-I-like receptor signaling pathway CXCL10 ↑, Q1KLR3 ↑, IFIH1 ↑, IL8 ↑ 70 0.000815541
Activation of NMDA receptor upon glutamate binding and
postsynaptic events
ADCY1 ↓, GRIN2A ↓, GRIN2C ↓ 32 0.002998833
Post NMDA receptor activation events ADCY1 ↓, GRIN2A ↓, GRIN2C ↓ 32 0.002998833
Long-term potentiation ADCY1 ↓, GRIN2A ↓, GRIN2C ↓, ITPR1 ↓ 68 0.003241851
Cytosolic DNA-sensing pathway CXL10 ↑, Q1KLR3 ↑, ZBP1 ↑ 55 0.003482075
Transmission across Chemical Synapses ADCY1 ↓, GRIN2A ↓, GRIN2C ↓, SLC6A3 ↓ 76 0.00456686
Synaptic Transmission ADCY1 ↓, GRIN2A ↓, GRIN2C ↓, SLC6A3 ↓ 81 0.005631178
Gata3 participate in activating the th2 cytokine genes expression ADCY1 ↓, IL1A ↑ 18 0.007137619
D-Arginine and D-ornithine metabolism DAO ↓ 1 0.007150141
Neuroactive ligand-receptor interaction CALRL ↑, A6QQP6 ↑, GRIK3 ↓, GRIN2A ↓, GRIN2C
↓, TRY2 ↑
301 0.009258012
Neuroransmitter Receptor Binding And Downstream Transmission
In The Postsynaptic Cell
ADCY1 ↓, GRIN2A ↓, GRIN2C ↓ 48 0.009603978
Unblocking of NMDA receptor, glutamate binding and activation GRIN2A ↓, GRIN2C ↓ 12 0.009663882
Expression is Restricted Anovulatory relative to Control. eg. CXL10 ↑ means RA has increased expression compared to C
Table 4 Enriched genetic pathways between Restricted Ovulatory and Control groups from Innatedb
Pathway name Genes Total no. of genes in pathway P value
Apoptotic cleavage of cell adhesion proteins CADH1 ↓, DSP ↓ 11 7.81E-05
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell CADH1 ↓, Q05B55 ↓, 74 0.001265006
Apoptotic cleavage of cellular proteins CADH1 ↓, DSP ↓ 36 0.001499709
Arf6 trafficking events CADH1 ↓, TSHR ↓ 39 0.001743312
Apoptotic execution phase CADH1 ↓, DSP ↓ 42 0.001980774
Proteinase-activated receptor G (12/13) cascade PAR1 ↓ 3 0.003148078
Thrombin-mediated activation of PARs PAR1 ↓ 4 0.004671547
Platelet Activation PAR1 ↓, TSP4 ↓ 95 0.005884444
Signaling by GPCR PAR1 ↓, TSHR ↓ 648 0.006837614
Classical antibody-mediated complement activation Q05B55 ↓ 24 0.007641167
Proteinase-activated receptor G (q) cascade PAR1 ↓ 6 0.007793549
Thrombin signalling G-protein cascades PAR1 ↓ 6 0.007793549
Sumoylation as a mechanism to modulate ctbp-dependent gene responses CADH1 ↓ 8 0.008891268
Formation of Platelet plug PAR1 ↓, TSP4 ↓ 114 0.00923053
Thrombin signalling through PARs PAR1 ↓ 7 0.009310227
Expression is Restricted Ovulatory relative to Control. eg. CADH1 ↓ means RO has decreased expression of this compared to C
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desmosome which occurs at intercellular junctions that
tightly link adjacent cells. TSP4 encodes thrombospon-
din 4, an adhesive glycoprotein that mediates cell to cell
interactions. Cellular motility or neuronal plasticity have
previously been up-regulated in rodents when diet was
reduced, and it has been suggested that this may con-
tribute to a neuroprotective role in animals undergoing
reduced dietary intake, as these processes are important
in both learning and memory [23–25]. Another gene
with decreased expression in RO relative to C was PAR-
1. Activation of either PAR-1 or PAR-2 may also have a
neuroprotective effect [26, 27], and this is believed to be
due to mesotrypsinogen/trypsinogen IV activation. How-
ever, no trypsinogen gene displayed increased expression
in RO v C. It is therefore possible that there is less of a
neuroprotective effect of diet restriction on the RO
group. This is further compounded by the fact that nei-
ther IL-1α nor IL-1β were differentially expressed in RO
relative to C, indicating that the RO group were not
forced to choose between survival and protection of the
brain or reproduction.
Thyroid stimulating hormone receptor (TSHR) had de-
creased expression in RO v C. Thyroid stimulating hor-
mone (TSH) binds to TSHR, as does thyroid releasing
hormone (TRH) to regulate the secretion of the thyroid
hormones through a negative feedback loop. The thyroid
hormones (T3 and T4) increase metabolism, growth and
proliferation. Stimulation of TSHR can result in in-
creased secretion of thyroid hormones. It is therefore
possible that TSHR has reduced expression in RO to
prevent the secretion of T3 and T4 which would use up
energy that the RO group may not have had. This shows
that the RO group were under a certain amount of pres-
sure from the diet restriction but not to the same extent
as RA. All animals will become anovulatory eventually
under severe long term diet restriction and perhaps re-
duced expression of TSHR in order to save available en-
ergy occurs at the beginning of the process in the shift
to anovulation.
Restricted Anovulatory v Control
Immune response
Signals generated by the hypothalamic-pituitary-gonadal
(HPG) axis powerfully modulate immune system func-
tion [28]. Following pathway analysis the most over-
represented pathway within the RA v C comparison was
RIG-I-like receptor signalling pathway of which four
genes (CXCL10, Q1KLR3, IFIH1, and IL8), all of which
have roles in immune function, were up-regulated in RA
relative to C. The gene, CXCL10 encodes a chemokine
of the CXC subfamily which binds to CXCR3. Binding of
the CXCL10 protein to CXCR3 results in pleiotropic ef-
fects, including stimulation of monocytes, natural killer
and T-cell migration, and modulation of adhesion
molecule expression. It has been suggested that along
with the significant role chemokines play in immune
response, they may be added to the multiple peptides
involved in the regulation of neuroendocrine path-
ways [29].
Both CXCL10 and IL8, had increased expression in RA
relative to C and have proven functions in reducing feed
intake in rats [30]. In addition, IL1α, another immune
functioning gene, had increased expression in RA v C.
There are two forms of IL-1, IL-1α and IL-1β, and in
most studies their biological activities are indistinguish-
able [31]. Both versions of IL-1 also bind to the same ac-
tive receptor, IL-1R [31]. IL-1 has an anorexic effect in
rats by stimulating the release of corticotropin releasing
factor (CRF) in the hypothalamus [32], which acts to re-
duce food intake. In our study CXCL10, IL8 and IL1α
Table 5 Enriched genetic pathways between Restricted Anovulatory and Restricted Ovulatory groups from Innatedb
Pathway name Genes Total no. of genes
in pathway
P value
Neuroactive ligand-receptor
interaction
PACA ↑, AGRP ↑, AGTR1 ↓, A6QL98 ↑, A4IFF5 ↑, CALRL ↑, A6QHL2 ↑, Q9BGU4 ↓,
C6KEA7 ↑, PAR1 ↑, A6QQP6 ↑, GBRR2 ↓, GHR ↑, SLIB ↑, GPR83 ↑, GRIK3 ↓, GRIN2A ↓,
GRIN2B ↓, GRIN2C ↓, GRM4 ↓, HRH1 ↑, 5HT2A ↑, MC4R ↑, NPY ↑, NTSR1 ↓, TRY2 ↑,
PF2R ↑, S1PR5 ↓, TKN1 ↑, TSHR ↑
301 0.000211925
Toll-like receptor signaling pathway Q2LGB8 ↑, CD14 ↑, Q1JPC5 ↑, CXL10 ↑, CXCL9 ↑, FADD ↓, IL1B ↑, A6QQK2 ↓,
PIK3CD ↓, A4IFU4 ↑, TLR2 ↑, TLR3 ↑, TLR4 ↑
101 0.00365653
Caspase8 activation signalling Q2LGB8 ↑, FADD ↓ 2 0.004011647
Systemic lupus erythematosus Q3SYT3 ↑, C1S ↑, Q1JPC5 ↑, FCGR2 ↑, FCGR3 ↑, GRIN2A ↓, GRIN2B ↓, Q17QG8 ↓,
RO52 ↑
95 0.004188484
Signaling by GPCR ADCY1 ↓, PACA ↑, AGTR1 ↓, A6QL98 ↑, ARHGEF1 ↓, CALRL ↑, A6QHL2 ↑, CCR5 ↑,
Q9BGU4 ↓, C6KEA7 ↑, CXL10 ↑, CXCL9 ↑, PAR1 ↑, SLIB ↑, A2VEA2 ↓, GRM4 ↓,
HRH1 ↑, 5HT2A ↑, MC4R ↑, NPY ↑, NTSR1 ↓, OR2W3 ↓, PDE8B ↑, LOC785870 ↑,
LOC616798 ↓, PF2R ↑, RGR ↓, S1PR5 ↓, TKN1 ↑, TSHR ↑
648 0.004475761
Class A/1 (Rhodopsin-like receptors) AGTR1 ↓, A6QL98 ↑, A6QHL2 ↑, CCR5 ↑, CXL10 ↑, CXCL9 ↑, PAR1 ↑, A2VEA2 ↓,
HRH1 ↑, 5HT2A ↑, MC4R ↑, NPY ↑, NTSR1 ↓, LOC785870 ↑, PF2R ↑, RGR ↓, S1PR5 ↓,
TKN1 ↑, TSHR ↑
222 0.006932285
Expression is Restricted Anovulatory relative to Restricted Ovulatory. eg. PACA ↑ means expression is higher in RA compared to RO
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were not responsible for reduced feed intake as dietary re-
striction was imposed upon experimental animals. How-
ever, the immune system has been shown to possess the
ability to block normal reproductive functioning [33].
Both IL-1β and IL-1α have been shown to suppress
(through blocking GnRH secretion) and interfere with LH
release, respectively [34, 35]. These results show that IL-1
is a strong suppressant of GnRH secretion and therefore
reproduction, possibly explaining why an alteration in im-
mune response genes was evident in RA compared to C.
Table 6 Enriched genetic pathways in all comparisons from in IPA
Pathway name Genes Total no. of genes
in pathway
P value
Restricted Anovulatory v Control
Activation of IRF by Cystosolic Pattern
Recognition Receptors
DDX58 ↑, IFIH1 ↑, IFIT2 ↑, ZBP1 ↑ 72 0.00073
Interferon Signalling IFIT1 ↑, IFIT3 ↑, MX1 ↑ 36 0.00135
Role of Hypercytokinemia/hyperchemokinemia
in the Pathogenesis of
Influenza
CXCL10 ↑, IL8 ↑, IL1A ↑ 44 0.00286
Synaptic Long Term Potentiation ADCY1 ↓, GRIN2A ↓, GRIN2C ↓, ITPR1 ↓ 114 0.00461
CREB Signalling in Neurons ADCY1 ↓, GRIK3 ↓, GRIN2A ↓, GRIN2C ↓, ITPR1 ↓ 202 0.00515
Calcium Signalling CHRNA2 ↓, GRIN2A ↓, GRIN2C ↓, ITPR1 ↓, MYH11 ↑ 207 0.00541
Glutamate Receptor Signalling GRIK3 ↓, GRIN2A ↓, GRIN2C ↓ 69 0.00595
D-arginine and D-ornithine Metabolism DAO ↓ 18 0.00646
Glycosphingolipid Biosynthesis –
Neolactoseries
ST3GAL6 ↑, ST8SIA5 ↓ 64 0.00957
Restricted Ovulatory v Control
Gα12/13 Signalling CDH1 ↓, F2R ↓ 128 0.00767
Restricted Anovulatory v Restricted Ovulatory
LXR/RXR Activation APOA4 ↓, CCL2 ↑, CD14 ↑, IL1A ↑, IL1B ↑, MSR1 ↑, NR1H2 ↓, PTGS2 ↑,
RXRG ↑, SREBF1 ↓, TLR3 ↑, TLR4 ↑
93 0.000344
Germ Cell-Sertoli Cell Junction Signaling A2M ↑, ACTG2 ↑, AXIN1 ↓, BCAR1 ↓, EPN1 ↓, EPN2 ↓, GSN ↓, IQGAP1 ↑,
JUP ↓, LAMC3 ↓, MAP3K9 ↓, MAP3K11 ↓, PIK3CD ↓, PVRL2 ↓, RHOT2 ↓,
RND3 ↑, TUBA8 ↓, ZYX ↓
167 0.000870
TREM1 Signaling CASP5 ↑, CCL2 ↑, CD86 ↑, FCGR2B ↑, ICAM1 ↑, IL1B ↑, TLR2 ↑, TLR3 ↑, TLR4 ↑ 66 0.00125
Neuropathic Pain Signaling In Dorsal Horn
Neurons
GRIN2A ↓, GRIN2B ↓, GRIN2C ↓, GRM4 ↓, KCNH2 ↓, KCNN1 ↓, KCNQ2 ↓,
KCNQ3 ↓, PIK3CD ↓, PLCH2 ↓, PRKCG ↓, PRKCH ↓, TAC1 ↑
108 0.00133
Hepatic Fibrosis / Hepatic Stellate Cell
Activation
A2M ↑, AGTR1 ↓, CCL2 ↑, CCR5 ↑, CD14 ↑, CXCL9 ↑, FLT1 ↑, ICAM1 ↑,
IGFBP5 ↓, IL1A ↑, IL1B ↑, KDR ↑, MYH11 ↑, MYH14 ↓, STAT1 ↑, TLR4 ↑
147 0.00159
Reelin Signalling in Neurons APBB1 ↓, ARHGEF1 ↓, ARHGEF10 ↓, ARHGEF16 ↓, CDK5R1 ↓, MAP3K9 ↓,
MAP3K11 ↓, MAPK8IP1 ↓, MAPK8IP3 ↓, PIK3CD ↓, RELN ↑
82 0.00175
G-Protein Coupled Receptor Signalling ADCY1 ↓, AGTR1 ↓, APLNR ↑, C3AR1 ↑, CALCRL ↑, CCKAR ↑, CCR5 ↑,
CRHR1 ↓, CX3CR1 ↑, CXCR7 ↓, DUSP4 ↓, ELTD1 ↑, F2R ↑, FZD6 ↑, GPR17 ↓,
GPR83 ↑, GPR116 ↑, GPR123 ↓, GPR126 ↑, GPR133 ↑, GPR137 ↓, GPR153 ↓,
GPR179 ↑, GPR172B ↓, GRM4 ↓, HRH1 ↑, HTR2A ↑, LPHN3 ↑, MC4R ↑,
NTSR1 ↓, PDE8B ↑, PIK3CD ↓, PRKCG ↓, PTGFR ↑, PTK2B ↓, RAPGEF3 ↓, RGR ↓,
RGS16 ↓, S1PR5 ↓, TSHR ↑
529 0.00314
Circadian Rhythm signalling ADCYAP1 ↑, CRY2 ↓, GRIN2A ↓, GRIN2B ↓, GRIN2C ↓, PER1 ↓ 35 0.00374
Axonal Guidance Signalling ABLIM3 ↑, ADAM11 ↓, ADAM15 ↓, ADAM28 ↑, BCAR1 ↓, CXCR4 ↑, EFNA5 ↑,
EPHB6 ↓, FZD6 ↑, GIT1 ↓, GNB1L ↓, GNG4 ↑, GNG7 ↓, LINGO1 ↓, MAG ↓,
PIK3CD ↓, PLXNA2 ↓, PLXNB1 ↓, PLXNC1 ↑, PRKCG ↓, PRKCH ↓, SEMA3E ↓,
SEMA4C ↓, SEMA4D ↓, SEMA4F ↑, SEMA6B ↓, SEMA7A ↓, SLIT1 ↑, SLIT2 ↑,
TUBA8 ↓, UNC5B ↓
432 0.00706
Glycerolipid Metabolism ALDH1A1 ↓, ALDH4A1 ↓, DAGLA ↓, DGAT2 ↑, DGKQ ↓, DHRS4 ↓, GLYCTK
↓, LIPE ↓, LIPN3 ↓, MGLL ↓, PPAP2C ↓,
148 0.00798
Pathogenesis of Multiple Schlerosis CCR5 ↑, CXCL9 ↑, CXCL10 ↑ 9 0.00819
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Neuroprotection
An alternative reason for these immune genes to be
switched on in the hypothalamus following diet restric-
tion is that the energy deficit forces the body to decide
between reproduction or immune function. In the tree
lizard, albeit quite distant to the cow, when energy re-
serves are tight there is competition between immune
function and reproduction [36]. The most important
organ to the body’s survival is the brain and so it is
plausible that the immune genes mentioned have in-
creased expression to facilitate a neuroprotective effect.
It has been well documented in rodents that diet restric-
tion increases longevity [37], but diet restriction is also
known to have a neuroprotective effect [38, 39]. Much
of this neuroprotection during diet restriction comes
about from neurotrophins including BDNF [40, 41]; NT-
3 [41]; NGF and; NT-4/5, which promote the survival of
neurons. None of these genes had increased expression
in RA v C, however, IL-1 has been shown to stimulate
the expression of NGF mRNA [42–45] possibly elucidat-
ing a mechanism whereby immune genes, particularly
IL-1, are up-regulated in RA to protect the brain. It is
very possible that the immune genes are carrying out
both functions, preventing secretion of GnRH and per-
forming a neuroprotective role to ensure the brain con-
tinues to function as a priority.
Further evidence to the body protecting the brain dur-
ing diet restriction is the over expression of trypsinogen
genes. In the RA v C comparison TRY2 and PRSS3 were
over expressed. The PRSS3 gene encodes, due to alterna-
tive splicing, both mesotrypsinogen and trypsinogen 4
[46]. It has been proposed that mesotrypsinogen/tryp-
sinogen IV, via activation of Proteinase-activated recep-
tor 1 (PAR-1) or Proteinase-activated receptor 2 (PAR-
2), might contribute to neuroprotection in the rat brain
[27]. Increased expression of trypsinogen was potentially
carrying out a similar function and aiding neuroprotec-
tion during diet restriction.
Restricted Anovulatory v Restricted Ovulatory
Energy homeostasis
It is interesting to note that although on the same re-
stricted diet, the comparison between RA and RO
returned the largest number of SDE. On initial analysis,
there appears to be a considerable response in the hypo-
thalamus to attempt to return the animal to a positive
energy balance. PACA, also known as PACAP, was in-
creased in RA relative to RO. This encodes adenylate
cyclase activating polypeptide 1, which acts as a neuro-
transmitter and neuromodulator. PACA stimulates insu-
lin secretion from the pancreas in mice [47, 48], calves
[49] and humans [50]. PACA also stimulates an increase
in plasma vasopressin concentrations [51–53]. Vasopres-
sin is key to homeostasis as it regulates water, glucose
and salt levels in the blood. Additionally, injection of
PACA in the medial basal hypothalamus of ovariecto-
mized ewe has been shown to suppress LH secretion
and pulse frequency [54]. This action is presumably
through an inhibition of GnRH. Increased PACA in the
RA group may be preventing any LH secretion while
also increasing the secretion of vasopressin to maximize
blood glucose concentrations.
Two genes that potently increase food intake; AgRP
and NPY had increased expression in RA v RO. AgRP is
almost exclusively expressed in the CNS [55, 56], where
its gene product increases food intake as it acts as an an-
tagonist to melanocortin-3 receptor (MC3R) and
melanocortin-4 receptor (MC4R) [57, 58]. Activation of
MC4R by its agonist α-melanocyte-stimulating hormone
(α-MSH), results in decreased food intake [59]. Consist-
ent with this, MC4R also had increased expression in
RA v RO. Similar results have been observed previously
in mice where AgRP and NPY had increased hypothal-
amic expression during negative energy balance [60].
AgRP expressing neurons in the hypothalamus have
been shown to express NPY [61], indicating a close
working relationship between these neuropeptides in the
hypothalamus. Recently, Allen et al. [13] showed marked
differences in the expression of NPY and AGRP in the
hypothalamus of heifers nutritionally programmed to
hasten pubertal onset suggesting that they interact to
regulate the reproductive neuroendocrine axis in cattle.
NPY is believed to be the most potent elicitor of food
intake [62]. However, the literature provides evidence of
both an inhibitory [63] and a stimulatory role [64] on
LH secretion in rodents. NPY is believed to exert its ef-
fects on LH through GnRH [64–66] which is dose de-
pendant and influenced by stage of cycle. In order for
NPY to have an excitatory effect on GnRH release, inter-
mittent hypothalamic NPY receptor activation is re-
quired, whereas continuous activation appears to inhibit
LH release [67]. In the many studies on ovariectomized
mammals, administration of NPY invariably causes an
inhibition on GnRH levels [66, 68–71]. Therefore, in
order for NPY to have a positive effect on GnRH, suit-
able ovarian steroid concentrations must exist and NPY
receptor activation must be intermittent. If either of
these factors are not satisfactory, NPY will suppress
GnRH. The increased expression of NPY in RA heifers
may chronically activate its receptor and therefore in-
hibit GnRH release. Furthermore, both estradiol and
progesterone plasma concentrations were lowest in RA
heifers [72] and may have contributed to NPY inhibiting
GnRH.
Diet restriction or fasting increases hypothalamic NPY
concentrations [71, 73] and mRNA [74] in sheep, and
rats [75]. It is therefore surprising that RA had higher
NPY expression than RO considering both groups were
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fed the same restricted diet. However, it has been previ-
ously observed in rats that peripheral insulin administra-
tion suppresses NPY release in the hypothalamic
paraventricular nucleus (PVN) [76]. Additionally, central
administration of insulin decreases both NPY mRNA
and NPY concentrations in hypothalamic areas [77].
These findings suggest that the increase in NPY in re-
sponse to fasting is dependent on low insulin levels. As
documented in our previous study [72], using the same
animals, insulin and IGF-1 concentrations were higher
in RO compared to the two other groups on days −2
and 0. As the feeding phase progressed concentrations
of these hormones decreased in both RO and RA and
were similar by day 9 and remained stable until slaugh-
ter. It is therefore likely that the reason RO heifers do
not become anovulatory during diet restriction is that
their initially higher insulin, and possibly IGF-1, concen-
trations prevent an increase in NPY at sufficiently high
concentrations to inhibit GnRH. A considerable carry
over effect of this was observed. All heifers had two op-
portunities to ovulate. Within RA four heifers ovulated
the 1st dominant follicle (DF) but failed to ovulate the
2nd DF even though insulin and IGF-1 concentrations
were lower in RA from the outset. This suggests that it
takes some time for metabolic messages, possibly
through NPY, to block GnRH in cattle. The prolonged
time taken to prevent GnRH release may explain why
RO heifers ovulated the 2nd DF even though insulin
levels and IGF-1 levels were almost similar to RA heifers
at that stage. NPY has been described as one of the es-
sential messenger molecules that serve as a communica-
tion bridge between neural processes that regulate
reproduction and energy homeostasis [67], and data
from this study certainly supports that finding.
Other genes with roles in energy homeostasis had al-
tered expression in the RA v RO comparison. AGTR1
which encodes type-1 angiotensin II receptor, function-
ing in salt and thirst desire had decreased expression in
RA. A6QL98 encodes the apelin receptor which is simi-
lar to the angiotensin receptor. This receptor had in-
creased expression in RA. Apelin increases water intake
in rats following administration [78, 79]. It also has a di-
uretic effect which may work by decreasing vasopressin
levels in the hypothalamus [80]. Apelin is also believed
to exert an effect on food intake but its role is contra-
dictory. Taheri et al. [79] found no effect of centrally ad-
ministered apelin on food intake. However, another
study found the exact opposite effect when apelin was
centrally administered in rats [81]. One possible reason
for this inconsistency is circadian rhythm. It has been
observed in rats that i.c.v. injection of apelin during the
night has a dose dependent reduction in food intake 2–
4 h after injection. Yet, day-time administration of apelin
to satiated rats stimulated feeding [82]. If apelin exerts
an inhibitory effect on feed intake in cattle, it would be
consistent with the theory that RA heifers have in-
creased expression of certain genes in an attempt to
stimulate food intake. This is due to the apelin receptor
having increased expression perhaps reflecting that there
was a decreased requirement for apelin stimulated food
inhibition in RA.
Similarly, in our study, A6QHL2 encoding
cholecystokinin-A receptor had increased expression in
RA. A cholecystokinin-A receptor knock-out study in
mice showed that cholecystokinin diminished food in-
take by up to 90% through its receptor [83]. The fact
that the receptor had increased expression suggests that
it was not activated in RA heifers therefore its food in-
hibition function did not occur. Q9BGU4 encodes the
corticotropin releasing hormone receptor 1 (CRF-R1).
This gene had reduced expression in RA v RO. CRF in-
hibits food intake so possibly the CRF-R is reduced in
RA so any CRF produced by stress response cannot fulfil
its role in the reduction in food intake but can stimulate
adrenocorticotropic hormone (ACTH) secretion. In con-
trast, C6KEA7 which encodes corticotropin releasing
hormone receptor 2 had increased expression in RA.
CRF is primarily involved in the stress response by
stimulating the synthesis and release of ACTH from the
anterior pituitary gland, which in turn stimulates the re-
lease of glucocorticoids from the adrenal gland. Cortisol
levels rise during periods of fasting in humans [84], and
this is presumably through an increase of CRF in the
hypothalamus. Cortisol stimulates gluconeogenesis, par-
ticularly in the liver while also inhibiting glucose uptake
in muscle and adipose tissue in order to conserve glu-
cose levels. Data from our previous study [72] using the
same animals, showed that glucose levels were un-
affected by group suggesting a possible reason for this
observation. Cortisol also stimulates lipolysis in adipose
tissue. Both restricted groups, RA and RO, had elevated
beta hydroxybutyrate (BHB) levels compared to C, indi-
cating a greater amount of lipolysis was occurring in
these animals. There are therefore reasons for the CRF
receptors to have increased expression in RO.
The fact that these genes (AgRP, NPY, MC4R,
A6QL98, A6QHL2, Q9BGU4) which are heavily in-
volved in increasing food intake were up-regulated in
RA relative to RO even though both groups were on
the same restricted individually fed diet reinforces that
RA animals are in a greater energy deficit. All animals
on a restricted diet will eventually come to a point
where the decision must be made to cease reproductive
functioning in order to increase the chances of survival.
Data shows that RA are forced to make that decision
sooner due to lower plasma IGF-1 and insulin levels,
which are most probably due to underlying genetic
variation in the animals.
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Immune response
The second observation from the data is that, similar to
that observed in RA v C, there was a considerable im-
mune response in RA relative to RO. Genes such as
CXL10, CXCL9, IL-1β, and IL-1α all had increased ex-
pression. This again was somewhat surprising as both
groups were on the same diet. However, this proves that
RA were in a deeper energy deficit than RO and there-
fore had to up-regulate immune genes for neuroprotec-
tion. IL-1β and IL-1α were in the top 10% of increased
fold change genes in RA relative to RO. TRY2 also had
increased expression in RA and as mentioned trypsino-
gens in the brain are linked with neuroprotection. Due
to the GnRH suppressant role of NPY it is more likely
that the immune genes IL-1α and IL-1β do not initially
cause anovulation but rather add to the prevention of a
re-initiation of the oestrous cycle by GnRH, along with
PACA and NTSR1.
Prevention of GnRH secretion
NTSR1 had reduced expression in RA heifers and this
along with other SDE genes IL1α, IL1β, NPY and PACA,
may act as a method to reduce any LH surge in order to
conserve all available energy for biological processes
more important to survival. NTSR1 encodes neurotensin
receptor 1. Neurotensin has been implicated in the regu-
lation of GnRH/LH release. In the rat, GnRH neurons
co-express mRNA for NTSR1, suggesting that GnRH
neurons may be direct targets for activation by neuro-
tensin [85]. It has also been observed that administration
of neurotensin directly in the preoptic area of the hypo-
thalamus evokes LH secretion [86, 87]. Furthermore, a
blockade of neurotensin signalling reduces the LH surge
in the rat [88]. In mice however, neurotensin is thought
not to play a direct role in generating the GnRH/LH
surge but is regulated by E2 [89].
Conclusions
Evidence in this study indicates that heifers became
anoestrus following a period of diet restriction. Bio-
logical processes affected by dietary restriction in hypo-
thalami included immune response, neuroprotection,
cell motility and energy homeostasis. Increased expres-
sion of molecules within the hypothalamus provided the
GnRH neurons with information that body reserves were
not adequate to continue oestrous cyclicity following re-
striction (Fig 1). There was a delay in this information
being sent to the GnRH neurons in RO heifers due to
higher initial concentrations of insulin and possibly IGF-
1. This was particularly true for NPY. The reasoning for
RO heifers having higher IGF-1 and insulin concentra-
tions than RA heifers on a similar level of feeding (days
−2 and 0) requires more research. However, a possibility
is a more efficient utilisation of feed due to underlying
genetic variation. The findings presented here for the
first time point to a possible molecular mechanism for
increased tolerance to an energy deficit in the cow, and
assist in the overall understanding of the effects of NEB
on fertility in the cow.
Methods
All animal procedures performed in this study were con-
ducted under experimental licence from the Irish De-
partment of Health and Children (licence number B100/
846).in accordance with the Cruelty to Animals Act
1876 and the European Communities (Amendment of
Cruelty to Animals Act 1876) Regulation 2002 and 2005.
Procedures were carried out in accordance with Regula-
tion 12 of the European Communities Regulations
2006 S.I. 612 of 2006 and were sanctioned by the Re-
search Ethics Committee, University College Dublin
(UCD), Ireland.
Experimental model
A short term (18-day) dietary restriction model was devel-
oped which induced abrupt onset of anoestrus in some
animals while others maintained oestrous cyclicity [17,
72]. Briefly, in that study 40 Charolais-crossbred heifers
exhibiting regular oestrous cycles with an initial liveweight
(mean ± SEM) and BCS of 395 ± 3.7 kg, and 2.99 ± 0.04,
respectively, were used. Oestrus was synchronised using
an 8 day combined CIDR and prostaglandin F2α regimen.
During the oestrous synchronisation period all heifers
were fed a diet supplying 1.2 estimated maintenance en-
ergy requirements (Mn). One day before CIDR removal
(day 0), heifers were allocated randomly to either a diet
supplying 0.4 Mn (n = 28) or retained on 1.2 Mn (C;
n = 12). Following CIDR removal, ovarian follicular
growth and ovulation were monitored using transrectal
ultrasonography. On the 11th day after diet allocation,
prostaglandin F2α (PGF2α) was administered to induce
luteolysis, oestrus and ovulation. Within 0.4 Mn, animals
were classified as either restricted ovulatory (RO) or re-
stricted anovulatory (RA) depending on whether the DF
ovulated or failed to ovulate, respectively. Heifers were
blood sampled on days −2, 0–17 and again at slaughter
(day 18) for the metabolic hormones IGF-1, insulin, leptin,
glucose, BHB, and urea, and the reproductive hormones
P4 and E2. After 18 days of feeding all heifers were slaugh-
tered in a commercial abattoir and hypothalamic tissue
was recovered. The procedure used for harvesting of
hypothalamic tissue has been outlined previously by Mat-
thews [72]. A subset of animals was used for this particu-
lar study which consisted of 20 animals (6 C, 7 RO, 7 RA).
mRNA extraction
Hypothalami were collected, immediately snap frozen in
liquid nitrogen and subsequently stored at −80 °C. Total
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RNA was isolated using a lipid tissue midi kit (Qiagen
Ltd., West Sussex, UK) which includes a DNase step to
remove any genomic DNA contamination. RNA yield
and quality were assessed using automated capillary gel
electrophoresis on a Bioanalyzer 2100 with RNA 6000
Nano chips according to manufacturer’s instructions
(Agilent Technologies Ireland, Dublin, Ireland). Poly A
messenger RNA (mRNA) was purified from 10 μg total
RNA using Dynal oligo (dT) magnetic beads (Invitrogen,
Bio Sciences ltd., Dublin, Ireland). Oligo(dT) selection
was performed twice to ensure minimal carry-over of
ribosomal RNA (rRNA).
cDNA preparation
mRNA was fragmented and then reverse transcribed
into cDNA. Zinc mediated fragmentation was performed
by adding fragmentation reagent (Ambion, Applied Bio-
systems, Warrington, UK) to the mRNA and incubation
at 70 °C for 5 min. First strand cDNA synthesis was per-
formed using 3 μg of random hexamer primers and
SuperScript II (Invitrogen). After the first strand was
synthesized, second strand synthesis buffer, dNTPs,
RNase H and E. coli DNA polymerase I (Invitrogen)
were added and incubated for 2.5 h at 16 °C to translate
the second-strand synthesis. DNA was then purified
using a Qiaquick PCR spin column (Qiagen) and eluted
in 30 μl EB buffer (Qiagen).
Library preparation
The ends of cDNA fragments were repaired with a com-
bination of T4 DNA polymerase (New England BioLabs,
ISIS Ltd., Wicklow, Ireland) and E. coli DNA polymerase
I Klenow fragment (New England BioLabs) which re-
move 3′-overhangs and fill in 5′-overhangs. A single ‘A’
base was added to the 3′-end of blunt phosphorylated
cDNA fragments, using the polymerase activity of Kle-
now Exo fragment (New England BioLabs), to allow for
the ligation of adaptors which have a single 3′-T over-
hang. The ligated adaptors prepare the cDNA fragments
to be hybridized to a flow cell. DNA was purified using
Fig. 1 Schematic summary of the effect of diet restriction on heifers
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gel electrophoresis to allow for templates of uniform
length to be sequenced. Seventeen cycles of PCR enrich-
ment was performed on the purified adaptor ligated
cDNA templates. Adapter ligated cDNA fragment librar-
ies were run on an Illumina GAII using version 3 se-
quencing and single read cluster generation kits capable
of sequencing 42 bases of each template.
Read alignment and abundance calculations
RNA-seq reads from each flow cell lane were aligned sep-
arately to the Bos taurus genome (BCM4 genome assem-
bly) [90] using the ultrafast short read aligner Bowtie
version 0.12.5 [91]. Fastq output files from the sequencer
were used as input. The following options were specified
for bowtie processing: quality scores are ASCII characters
equal to the Phred quality scores plus 64 (−-Solexa1.3-
quals); the maximum number of mismatches allowed in
the first 28 bases is 2 (−n 2, −l 28); suppressing all align-
ments for any read that had more than 1 reportable align-
ment (−m 1); retained alignments were reported in SAM
format (−S).
Files were sorted according to location in the gen-
ome and any read duplicates were deleted in order to
normalise for PCR bias. The software package HTseq
(version 0.4.4p6) (http://pypi.python.org/pypi/HTSeq)
was used to calculate raw counts of transcript cover-
age for all annotated genes from the ENSEMBL v59
annotation of the bovine genome [92]. The counts for
all exons from the samples were collated into one file
and any gene with fewer than 5 reads in all samples
was excluded from the subsequent statistical analysis
of differential gene expression.
Identification of SDE genes and pathway analysis
Statistical analysis of gene expression was carried out
using DEseq (Version 1.1.11) [93] which uses a general-
isation of the Poisson model, the negative binomial dis-
tribution, to model biological and technical variance and
test for differential expression between two experimental
conditions. The statistical tests were corrected for mul-
tiple testing using the Benjamini and Hochberg (BH)
method [94] as implemented in R (version 2.12.0). SDE
genes were called at a FDR of 0.1, and these were
retained for further analysis. Reads were converted to
their human orthologs for gene ontology. Data were nor-
malised for gene length bias and genes were mapped to
the Innatedb database [95] for pathway analysis using
GOseq [96]. Data were also mapped to the IPA database
to gather as much information as possible regarding mo-
lecular events occurring in the hypothalamus due to
dietary restriction and its effect on reproductive per-
formance in the bovine.
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